KBC Group NV lowered its stake in shares of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) by 9.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 239,061 shares of the software maker’s stock after selling 23,790 shares during the period. KBC Group NV’s holdings in Allscripts Healthcare Solutions were worth $3,478,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of MDRX. Fisher Asset Management LLC purchased a new position in shares of Allscripts Healthcare Solutions during the 3rd quarter worth approximately $33,351,000. Systematic Financial Management LP boosted its position in shares of Allscripts Healthcare Solutions by 1,215.3% during the 3rd quarter. Systematic Financial Management LP now owns 1,853,300 shares of the software maker’s stock worth $26,372,000 after purchasing an additional 1,712,395 shares during the period. State Street Corp boosted its position in shares of Allscripts Healthcare Solutions by 28.6% during the 2nd quarter. State Street Corp now owns 5,975,551 shares of the software maker’s stock worth $76,251,000 after purchasing an additional 1,330,721 shares during the period. Janney Capital Management LLC boosted its position in shares of Allscripts Healthcare Solutions by 239.8% during the 3rd quarter. Janney Capital Management LLC now owns 997,009 shares of the software maker’s stock worth $14,187,000 after purchasing an additional 703,598 shares during the period. Finally, Community Trust & Investment Co. purchased a new position in shares of Allscripts Healthcare Solutions during the 4th quarter worth approximately $8,693,000.

Get Allscripts Healthcare Solutions alerts:

In other news, EVP Brian Farley sold 5,000 shares of the firm’s stock in a transaction on Thursday, December 14th. The shares were sold at an average price of $14.35, for a total value of $71,750.00. Following the sale, the executive vice president now directly owns 191,607 shares in the company, valued at approximately $2,749,560.45. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP James Hewitt sold 36,796 shares of the firm’s stock in a transaction on Friday, December 1st. The shares were sold at an average price of $14.11, for a total transaction of $519,191.56. Following the completion of the sale, the senior vice president now owns 181,766 shares in the company, valued at $2,564,718.26. The disclosure for this sale can be found here. Insiders sold a total of 56,796 shares of company stock worth $804,842 over the last 90 days. Company insiders own 0.91% of the company’s stock.

A number of research firms recently weighed in on MDRX. BidaskClub raised shares of Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating in a research report on Friday. TheStreet raised shares of Allscripts Healthcare Solutions from a “c” rating to a “b-” rating in a research report on Thursday. Wells Fargo & Co set a $19.00 price target on shares of Allscripts Healthcare Solutions and gave the company a “buy” rating in a research report on Saturday. Cantor Fitzgerald reissued a “buy” rating and issued a $17.00 price target on shares of Allscripts Healthcare Solutions in a research report on Sunday, January 28th. Finally, Evercore ISI began coverage on shares of Allscripts Healthcare Solutions in a research report on Thursday, January 18th. They issued an “outperform” rating and a $17.50 price target for the company. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and twelve have given a buy rating to the stock. Allscripts Healthcare Solutions has a consensus rating of “Buy” and an average price target of $15.85.

Shares of Allscripts Healthcare Solutions Inc (NASDAQ MDRX) opened at $13.83 on Monday. Allscripts Healthcare Solutions Inc has a fifty-two week low of $11.25 and a fifty-two week high of $16.13. The firm has a market cap of $2,498.82, a price-to-earnings ratio of 29.43, a PEG ratio of 1.95 and a beta of 1.18. The company has a debt-to-equity ratio of 1.33, a current ratio of 0.97 and a quick ratio of 0.98.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last announced its quarterly earnings data on Thursday, February 15th. The software maker reported $0.18 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.18. Allscripts Healthcare Solutions had a negative net margin of 10.88% and a positive return on equity of 7.36%. The business had revenue of $547.00 million for the quarter, compared to analyst estimates of $524.05 million. During the same period last year, the business earned $0.14 EPS. The company’s revenue was up 27.5% on a year-over-year basis. sell-side analysts anticipate that Allscripts Healthcare Solutions Inc will post 0.59 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Allscripts Healthcare Solutions Inc (MDRX) Shares Sold by KBC Group NV” was originally posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this piece on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.chaffeybreeze.com/2018/02/19/allscripts-healthcare-solutions-inc-mdrx-shares-sold-by-kbc-group-nv.html.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Want to see what other hedge funds are holding MDRX?Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allscripts Healthcare Solutions Inc (NASDAQ:MDRX).